CCA
FCSC

Conservest Capital Advisors’s Fibrocell Science Inc. FCSC Stock Holding History

Conservest Capital Advisors’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,333
Closed -$51K – 105
2017
Q3 		$51K Hold
3,333
– – 0.01% 103
2017
Q2 		$67K Hold
3,333
– – 0.01% 82
2017
Q1 		$33K Buy
+3,333
New +$37K 0.01% 84

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Conservest Capital Advisors's FCSC Position: Q4 2017 in Review

Conservest Capital Advisors sold out of Fibrocell Science Inc. (FCSC) in Q4 2017, closing a stake of 3,333 shares — an estimated $51K sold.

Conservest Capital Advisors first reported a position in FCSC in Q1 2017 and held it in 3 quarters. The position peaked at $67K in Q2 2017. 32 funds tracked by Wall St. Rank hold FCSC as of Q4 2017.

  • Conservest Capital Advisors reported no remaining Fibrocell Science Inc. position as of Q4 2017 after selling out during the quarter.
  • Conservest Capital Advisors sold 3,333 Fibrocell Science Inc. shares in Q4 2017, an estimated $51K.
  • Conservest Capital Advisors first reported a position in Fibrocell Science Inc. in Q1 2017 and held it in 3 quarters.
  • Conservest Capital Advisors's Fibrocell Science Inc. position peaked at $67K in Q2 2017.
  • 32 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2017.

Based on Conservest Capital Advisors's 13F filing for Q4 2017, filed 10 Jan 2018.